For people living with
diabetes and
end-stage kidney disease, a
simultaneous pancreas-kidney transplantation (SPKT) can restore insulin production while replacing failed kidney function. A new study published in
Cureus reports that carefully selected patients with
type 1 diabetes and
type 2 diabetes experienced similarly stable early blood sugar control and comparable short-term graft outcomes after the procedure, supporting a consistent approach to postoperative care ().
Researchers retrospectively evaluated
80 adult SPKT recipients treated between
2018 and 2025, including
31 patients with type 1 diabetes and
49 with type 2 diabetes. Although recipients with type 2 diabetes were older and had a higher
body mass index, their early postoperative glucose patterns were similar to those of recipients with type 1 diabetes.
Pancreas-Kidney Transplant Maintains Similar Early Blood Sugar Control
Blood glucose levels measured at
6, 12, and 24 hours after surgery and again on postoperative days
7, 14, and 28 showed no significant differences between the two groups. Likewise, the need for
intravenous insulin or
dextrose during the perioperative period was comparable, indicating similar early metabolic recovery following transplantation.
Short-Term Pancreas Graft Function Comparable in Both Diabetes Types
The researchers also found no meaningful differences in
insulin independence at one month,
delayed graft function,
pancreatic enzyme levels, postoperative complications, or hospital stay between the two groups. These findings suggest that early pancreas graft performance remains consistent regardless of diabetes type when recipients are carefully selected and managed using standardized perioperative protocols.
Study Supports Standardized Care After Pancreas-Kidney Transplant
The study adds evidence that
SPKT can provide comparable early metabolic outcomes for appropriately selected people with
type 1 and
type 2 diabetes. While longer-term follow-up and larger multicenter studies are still needed, these findings reinforce the feasibility of using uniform postoperative glucose management protocols and offer reassuring evidence that diabetes type alone may not influence early graft function after transplantation.
Reference:
- Immediate Glycemic Outcomes Following Simultaneous Pancreas�Kidney Transplantation: Equivalent Early Metabolic Profiles in Type 1 and Type 2 Diabetes - (https:www.cureus.com/articles/454753#!/)
Source-Medindia
-ACT,-2011.gif){kind=spacer}
